34 results on '"Cascallo, Manel"'
Search Results
2. Supplemental Figure 1 from The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
3. Supplemental Figure 4 from The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
4. Supplemental Figure 3 from The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
5. Supplemental Figure 2 from The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
6. Supplementary Data from Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors
7. Supplementary Methods, Figure Legends from Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency
8. Supplementary Figure 1 from Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency
9. Supplementary Figure 2 from Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency
10. Data from Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency
11. The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
12. VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects
13. Oncolytic viruses from the perspective of the immune system
14. A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to melanoma patients
15. Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
16. Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
17. The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
18. Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
19. Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
20. Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
21. Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors
22. Verapamil Enhances the Antitumoral Efficacy of Oncolytic Adenoviruses
23. Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy
24. Replacement of Adenovirus Type 5 Fiber Shaft Heparan Sulfate Proteoglycan-Binding Domain with RGD for Improved Tumor Infectivity and Targeting
25. Antitumor Therapy Based on Cellular Competition
26. Vero Cells as a Model to Study the Effects of Adenoviral Gene Delivery Vectors on the RNAi System in Context of Viral Infection
27. Coagulation Factors Determine Tumor TransductionIn Vivo
28. Bcl-2 Protects against p53-Induced Apoptosis through Hdm2
29. Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency
30. Coagulation factors determine tumor transduction in vivo
31. ICOVIR-5 Shows E2F1 Addiction and Potent Antiglioma Effect In vivo
32. Systemic Toxicity–Efficacy Profile of ICOVIR-5, a Potent and Selective Oncolytic Adenovirus Based on the pRB Pathway
33. Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting
34. Deletion of VAI and VAII RNA Genes in the Design of Oncolytic Adenoviruses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.